Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 2
1953 3
1954 3
1955 3
1956 2
1957 7
1958 3
1960 1
1961 6
1962 9
1963 13
1964 12
1965 9
1966 15
1967 22
1968 27
1969 26
1970 34
1971 23
1972 32
1973 28
1974 26
1975 29
1976 22
1977 32
1978 43
1979 41
1980 46
1981 45
1982 60
1983 72
1984 86
1985 99
1986 115
1987 114
1988 131
1989 123
1990 119
1991 107
1992 129
1993 153
1994 155
1995 172
1996 205
1997 191
1998 229
1999 241
2000 219
2001 245
2002 218
2003 216
2004 245
2005 276
2006 326
2007 336
2008 344
2009 291
2010 350
2011 366
2012 417
2013 430
2014 486
2015 435
2016 399
2017 453
2018 458
2019 463
2020 556
2021 669
2022 633
2023 500
2024 292

Text availability

Article attribute

Article type

Publication date

Search Results

11,518 results

Results by year

Filters applied: . Clear all
Page 1
Memory B cells.
Inoue T, Kurosaki T. Inoue T, et al. Nat Rev Immunol. 2024 Jan;24(1):5-17. doi: 10.1038/s41577-023-00897-3. Epub 2023 Jul 3. Nat Rev Immunol. 2024. PMID: 37400644 Review.
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC.
Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüroğlu M, Casarini I, Khiem DV, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, Huang X, Grainger E, Ghiorghiu D, van der Gronde T, Ramalingam SS; LAURA Trial Investigators. Lu S, et al. Among authors: inoue t. N Engl J Med. 2024 Jun 2. doi: 10.1056/NEJMoa2402614. Online ahead of print. N Engl J Med. 2024. PMID: 38828946
Evolutionary histories of breast cancer and related clones.
Nishimura T, Kakiuchi N, Yoshida K, Sakurai T, Kataoka TR, Kondoh E, Chigusa Y, Kawai M, Sawada M, Inoue T, Takeuchi Y, Maeda H, Baba S, Shiozawa Y, Saiki R, Nakagawa MM, Nannya Y, Ochi Y, Hirano T, Nakagawa T, Inagaki-Kawata Y, Aoki K, Hirata M, Nanki K, Matano M, Saito M, Suzuki E, Takada M, Kawashima M, Kawaguchi K, Chiba K, Shiraishi Y, Takita J, Miyano S, Mandai M, Sato T, Takeuchi K, Haga H, Toi M, Ogawa S. Nishimura T, et al. Among authors: inoue t. Nature. 2023 Aug;620(7974):607-614. doi: 10.1038/s41586-023-06333-9. Epub 2023 Jul 26. Nature. 2023. PMID: 37495687 Free PMC article.
Ocular clonus.
Yoshidome A, Yamasato K, Harada T, Ozawa H, Inoue T, Nakai M. Yoshidome A, et al. Among authors: inoue t. J Am Coll Emerg Physicians Open. 2023 Oct 16;4(5):e13055. doi: 10.1002/emp2.13055. eCollection 2023 Oct. J Am Coll Emerg Physicians Open. 2023. PMID: 37854954 Free PMC article. No abstract available.
This issue 30-12.
Inoue T. Inoue T. Int J Urol. 2023 Dec;30(12):1067. doi: 10.1111/iju.15339. Int J Urol. 2023. PMID: 38053319 No abstract available.
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial.
Krop IE, Masuda N, Mukohara T, Takahashi S, Nakayama T, Inoue K, Iwata H, Yamamoto Y, Alvarez RH, Toyama T, Takahashi M, Osaki A, Saji S, Sagara Y, O'Shaughnessy J, Ohwada S, Koyama K, Inoue T, Li L, Patel P, Mostillo J, Tanaka Y, Sternberg DW, Sellami D, Yonemori K. Krop IE, et al. Among authors: inoue t. J Clin Oncol. 2023 Dec 20;41(36):5550-5560. doi: 10.1200/JCO.23.00882. Epub 2023 Oct 6. J Clin Oncol. 2023. PMID: 37801674 Free PMC article. Clinical Trial.
RNA activation in ticks.
Kwofie KD, Hernandez EP, Anisuzzaman, Kawada H, Koike Y, Sasaki S, Inoue T, Jimbo K, Mikami F, Ladzekpo D, Umemiya-Shirafuji R, Yamaji K, Tanaka T, Matsubayashi M, Alim MA, Dadzie SK, Iwanaga S, Tsuji N, Hatta T. Kwofie KD, et al. Among authors: inoue t. Sci Rep. 2023 Jun 8;13(1):9341. doi: 10.1038/s41598-023-36523-4. Sci Rep. 2023. PMID: 37291173 Free PMC article.
Versatile utilities of amphibians (part 5).
Ochi H, Kato T, Zorn A, Hayashi T, Inoue T, Kondo M, Taira M, Michiue T. Ochi H, et al. Among authors: inoue t. Dev Growth Differ. 2023 Oct;65(8):459-460. doi: 10.1111/dgd.12889. Dev Growth Differ. 2023. PMID: 37881023 No abstract available.
Actinium-225 Targeted Agents: Where Are We Now?
Mourtada F, Tomiyoshi K, Sims-Mourtada J, Mukai-Sasaki Y, Yagihashi T, Namiki Y, Murai T, Yang DJ, Inoue T. Mourtada F, et al. Among authors: inoue t. Brachytherapy. 2023 Nov-Dec;22(6):697-708. doi: 10.1016/j.brachy.2023.06.228. Epub 2023 Sep 9. Brachytherapy. 2023. PMID: 37690972 Review.
11,518 results
You have reached the last available page of results. Please see the User Guide for more information.